420 related articles for article (PubMed ID: 23707797)
41. Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis.
Bae SC; Lee YH
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):74-79. PubMed ID: 29096759
[TBL] [Abstract][Full Text] [Related]
42. Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
Bossini-Castillo L; Simeon CP; Beretta L; Vonk MC; Callejas-Rubio JL; Espinosa G; Carreira P; Camps MT; Rodríguez-Rodríguez L; Rodríguez-Carballeira M; García-Hernández FJ; López-Longo FJ; Hernández-Hernández V; Sáez-Comet L; Egurbide MV; Hesselstrand R; Nordin A; Hoffmann-Vold AM; Vanthuyne M; Smith V; De Langhe E; Kreuter A; Riemekasten G; Witte T; Hunzelmann N; Voskuyl AE; Schuerwegh AJ; Lunardi C; Airó P; Scorza R; Shiels P; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Koeleman BP; Rueda B; Radstake TR; Martin J;
Rheumatology (Oxford); 2011 Nov; 50(11):1976-81. PubMed ID: 21875883
[TBL] [Abstract][Full Text] [Related]
43. CTLA-4 polymorphisms and susceptibility to inflammatory bowel disease: a meta-analysis.
Lee YH; Kim JH; Seo YH; Choi SJ; Ji JD; Song GG
Hum Immunol; 2014 May; 75(5):414-21. PubMed ID: 24530750
[TBL] [Abstract][Full Text] [Related]
44. [Interaction of MIF gene -173G/C polymorphism and GPX1 gene 594C/T polymorphism with high-fat diet in ulcerative colitis].
Zhang C; Guo L; Qin Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Feb; 33(1):85-90. PubMed ID: 26829742
[TBL] [Abstract][Full Text] [Related]
45. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata.
Shimizu T; Hizawa N; Honda A; Zhao Y; Abe R; Watanabe H; Nishihira J; Nishimura M; Shimizu H
Genes Immun; 2005 Jun; 6(4):285-9. PubMed ID: 15815686
[TBL] [Abstract][Full Text] [Related]
46. Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease.
Ji K; Wang X; Li J; Lu Q; Wang G; Xue Y; Zhang S; Qian L; Wu W; Zhu Y; Wang L; Liao L; Tang J
Biomed Res Int; 2015; 2015():315174. PubMed ID: 25821795
[TBL] [Abstract][Full Text] [Related]
47. The association between the migration inhibitory factor -173G/C polymorphism and cancer risk: a meta-analysis.
Zhang X; Weng W; Xu W; Wang Y; Yu W; Tang X; Ma L; Pan Q; Wang J; Sun F
Onco Targets Ther; 2015; 8():601-13. PubMed ID: 25792844
[TBL] [Abstract][Full Text] [Related]
48. Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.
Nohara H; Okayama N; Inoue N; Koike Y; Fujimura K; Suehiro Y; Hamanaka Y; Higaki S; Yanai H; Yoshida T; Hibi T; Okita K; Hinoda Y
J Gastroenterol; 2004; 39(3):242-6. PubMed ID: 15065001
[TBL] [Abstract][Full Text] [Related]
49. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy.
Hizawa N; Yamaguchi E; Takahashi D; Nishihira J; Nishimura M
Am J Respir Crit Care Med; 2004 May; 169(9):1014-8. PubMed ID: 14962818
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects.
Zhu H; Lei X; Liu Q; Wang Y
Cytokine; 2013 Jan; 61(1):146-53. PubMed ID: 23046617
[TBL] [Abstract][Full Text] [Related]
51. Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.
Yuan Q; Wang M; Wang M; Zhang Z; Zhang W
Mol Biol Rep; 2012 Mar; 39(3):3109-15. PubMed ID: 21750916
[TBL] [Abstract][Full Text] [Related]
52. A polymorphism in the macrophage migration inhibitory factor promoter is associated with bronchopulmonary dysplasia.
Prencipe G; Auriti C; Inglese R; Devito R; Ronchetti MP; Seganti G; Ravà L; Orzalesi M; De Benedetti F
Pediatr Res; 2011 Feb; 69(2):142-7. PubMed ID: 21045753
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
Saibeni S; Spina L; Virgilio T; Folcioni A; Borsi G; de Franchis R; Cugno M; Vecchi M
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
[TBL] [Abstract][Full Text] [Related]
54. Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis.
Cheng Y; Zhu Y; Huang X; Zhang W; Han Z; Liu S
PLoS One; 2015; 10(5):e0126803. PubMed ID: 26023918
[TBL] [Abstract][Full Text] [Related]
55. Serum macrophage migration inhibitory factor (MIF) in the intercritical phase of hereditary periodic fevers and its relationship with the MIF-173G/C polymorphism.
Rigante D; Flex A; Federico G; Pola R; Candelli M; Manna R; Pugliese AL; Cerquaglia C; Compagnone A; Stabile A
Scand J Rheumatol; 2007; 36(4):307-10. PubMed ID: 17763209
[TBL] [Abstract][Full Text] [Related]
56. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
Akyildiz M; Gunsar F; Nart D; Sahin O; Yilmaz F; Akay S; Ersoz G; Karasu Z; Ilter T; Batur Y; Berdeli A; Akarca U
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):192-8. PubMed ID: 19829123
[TBL] [Abstract][Full Text] [Related]
57. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
58. Association between the MIF-173G/C Polymorphism and Serum MIF levels with Pulmonary Tuberculosis: A Meta-analysis.
Tong X; Yan Z; Zhou Q; Liu S; Han J; Ma Y; Yang X; Fan H
Sci Rep; 2017 Mar; 7(1):234. PubMed ID: 28331211
[TBL] [Abstract][Full Text] [Related]
59. The role of polymorphisms of genes CXCL12/CXCR4 and MIF in the risk development IBD the Polish population.
Mrowicki J; Przybylowska-Sygut K; Dziki L; Sygut A; Chojnacki J; Dziki A; Majsterek I
Mol Biol Rep; 2014 Jul; 41(7):4639-52. PubMed ID: 24687413
[TBL] [Abstract][Full Text] [Related]
60. Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia.
Okazaki S; Hishimoto A; Otsuka I; Watanabe Y; Numata S; Boku S; Shimmyo N; Kinoshita M; Inoue E; Ohmori T; Someya T; Sora I
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():33-41. PubMed ID: 29305329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
